Health Insurance Innovations (HIIQ) Has 'Significant Upside' in Sale - Canaccord Genuity
Tweet Send to a Friend
Canaccord Genuity analyst Richard Close reiterated a Buy rating and $62.00 price target on Health Insurance Innovations ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
